AMN / AMN Healthcare Services, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

AMN Healthcare Services, Inc.
US ˙ NYSE ˙ US0017441017

Mga Batayang Estadistika
LEI 529900W3ARRTCNFH2I39
CIK 1142750
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to AMN Healthcare Services, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
August 8, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

August 7, 2025 EX-99.1

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2025 RESULTS Quarterly revenue of $658 million and Adjusted EBITDA of $58.3 million; GAAP loss of ($3.02)/share and adjusted EPS of $0.30

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2025 RESULTS Quarterly revenue of $658 million and Adjusted EBITDA of $58.

August 7, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2025 AMN HEALTHCARE SERVI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2025 AMN HEALTHCARE SERVICES, INC.

May 9, 2025 EX-10.2

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.2 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) Grant Date:   Grantee:   Units Granted:     THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E

May 9, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

May 9, 2025 EX-4.1

Description of Securities.*

Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 AMN Healthcare Services, Inc., a Delaware corporation, has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, par value $0.01 per share (“common stock”). References herein to the “Company,” “we,” “us”

May 9, 2025 EX-10.1

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.1 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) Grant Date:   Grantee:   Units Granted:   THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E T H: W

May 8, 2025 EX-99.1

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2025 RESULTS Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2025 RESULTS Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2025 financial results. Financial highlights are as fol

May 8, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2025 AMN HEALTHCARE SERVICES, INC.

May 5, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2025 AMN HEALTHCARE SERVICES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2025 AMN HEALTHCARE SERVICES, INC.

May 5, 2025 EX-FILING FEES

Filing Fee Table.

Calculation of Filing Fee Tables S-8 AMN HEALTHCARE SERVICES INC Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.

May 5, 2025 EX-10.1

AMN Healthcare 2025 Equity Plan.

Exhibit 10.1 AMN Healthcare 2025 Equity Plan SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the AMN Healthcare 2025 Equity Plan (as may be amended from time to time, the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, directors, and other key persons (including consultants and prospective employees) of AMN Healthcare Services, Inc.,

May 5, 2025 S-8

As filed with the Securities and Exchange Commission on May 5, 2025

As filed with the Securities and Exchange Commission on May 5, 2025 Registration No.

March 18, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule

March 18, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defi

February 21, 2025 EX-97.1

AMN Healthcare Services, Inc. Compensation Recoupment Policy.*

Exhibit 97.1 AMN HEALTHCARE SERVICES, INC. Compensation Recoupment Policy In accordance with the applicable rules of The New York Stock Exchange (the “NYSE Rules”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) has adopted this Policy to provide for the recovery of awarded Incentive-Bas

February 21, 2025 EX-21.1

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2024 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Interim Solutions, LLC Delaware AMN Healthcare Labor Disruption, Inc. California AMN Healthcare Language Services, Inc. Delaware A

February 21, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

February 21, 2025 EX-19.1

AMN Healthcare Services, Inc. Securities Trading Policy.*

Exhibit 19.1 Securities Trading Policy and Procedure Policy Overview This policy provides the standards of AMN Healthcare Services, Inc. (the “Company” or “AMN”) on trading (as defined in Part I.F below) and causing the trading of the Company’s securities. In accordance with applicable law, all employees, officers and directors of the Company and its subsidiaries and affiliates as well as such ind

February 21, 2025 EX-10.28

Form of Indemnification Agreement—Officer.*

Exhibit 10.28 INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is made as of , by and between AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Company”), and the individual named on the signature line below under the heading “INDEMNITEE” (“Indemnitee”). Preliminary Statements WHEREAS, the Company desires to attract and retain the services of highly qualified i

February 20, 2025 EX-99.1

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS Quarterly revenue of $735 million; GAAP loss of ($4.90)/share and adjusted EPS of $0.75

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS Quarterly revenue of $735 million; GAAP loss of ($4.90)/share and adjusted EPS of $0.75 DALLAS – (February 20, 2025) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 202

February 20, 2025 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 20, 2025 AMN HEALTHCARE SERVICES, INC.

February 7, 2025 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 4, 2025 AMN HEALTHCARE SERVICES, INC.

December 11, 2024 CORRESP

AMN HEALTHCARE SERVICES, INC. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019

AMN HEALTHCARE SERVICES, INC. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019 December 11, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, DC 20549 Attn: Stephen Kim and Lyn Shenk RE: AMN Healthcare Services, Inc. Form 10-K for the Fiscal Year ended December 31, 2023 File No. 001-16753 Dear Mr. Kim an

November 18, 2024 CORRESP

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019 November 18, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Stephen Kim and Lyn Shenk Division of Corporation Finance Office of Trade & Services Re: AMN Healthcare Services, Inc. Form 10-K for Fiscal Year Ended December 31, 2023

November 14, 2024 SC 13G/A

AMN / AMN Healthcare Services, Inc. / Boston Partners - BOSTON PARTNERS Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* AMN HEALTHCARE SERVICES INC (Name of Issuer) Common Stock (Title of Class of Securities) 001744101 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

November 12, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 9, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 9, 2024 AMN HEALTHCARE SERVICES, INC.

November 8, 2024 EX-10.1

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Executive (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.1 Executive Version AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT Grant Date: Grantee: Units Granted: THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcar

November 8, 2024 EX-10.2

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (TSR) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.2 Executive Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) Grant Date: Grantee: Units Granted: THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.   W I T N E S S E T H: WHEREA

November 8, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

November 8, 2024 EX-4.1

Fourth Amendment to Credit Agreement, dated as of November 5th, 2024, by and among AMN Healthcare, Inc., as borrow

Exhibit 4.1 EXECUTION VERSION FOURTH AMENDMENT TO CREDIT AGREEMENT THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of November 5, 2024, is entered into among AMN HEALTHCARE, INC., a Nevada corporation (the “Borrower”), AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Parent”), the Subsidiary Guarantors identified on the signature pages hereto, the lenders identifi

November 7, 2024 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2024 AMN HEALTHCARE SERVICES, INC.

November 7, 2024 EX-99.1

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2024 RESULTS Quarterly revenue of $688 million; GAAP EPS of $0.18 and adjusted EPS of $0.61

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2024 RESULTS Quarterly revenue of $688 million; GAAP EPS of $0.18 and adjusted EPS of $0.61 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2024 financial results. Financial highlights are as follows: Dol

October 24, 2024 CORRESP

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019 October 24, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, DC 20549 Attn: Stephen Kim and Lyn Shenk Re: AMN Healthcare Services, Inc. Form 10-K for the Fiscal Year Ended December 31, 2023 Form 10-Q for Fiscal Quarter Ended

October 7, 2024 CORRESP

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019 October 7, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Stephen Kim and Lyn Shenk Division of Corporation Finance Office of Trade & Services Re: AMN Healthcare Services, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 F

October 3, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 3, 2024 AMN HEALTHCARE SERVICES, INC.

October 3, 2024 EX-99.1

AMN Healthcare Appoints Brian Scott as CFO and COO Seasoned Healthcare Executive Brings Robust Financial Strategy Experience, Including Previous Role as Chief Financial Officer and Chief Accounting Officer of AMN for More Than 10 Years

EXHIBIT 99.1 AMN Healthcare Appoints Brian Scott as CFO and COO Seasoned Healthcare Executive Brings Robust Financial Strategy Experience, Including Previous Role as Chief Financial Officer and Chief Accounting Officer of AMN for More Than 10 Years DALLAS, October 3, 2024 – AMN Healthcare Services, Inc. (NYSE: AMN) (“AMN” or “the Company”), the leader and innovator in total talent solutions for he

October 1, 2024 EX-99.1

AMN Healthcare Announces CFO Transition Jeffrey Knudson to Step Down as CFO Following Company’s Q3 Report Company Expects to Announce New Leader in Expanded CFO/COO Role Prior to November 8 Reaffirms Third Quarter 2024 Outlook

EXHIBIT 99.1 AMN Healthcare Announces CFO Transition Jeffrey Knudson to Step Down as CFO Following Company’s Q3 Report Company Expects to Announce New Leader in Expanded CFO/COO Role Prior to November 8 Reaffirms Third Quarter 2024 Outlook DALLAS, October 1, 2024 - AMN Healthcare Services, Inc. (NYSE: AMN) (“AMN” or “the Company”), the leader and innovator in total talent solutions for healthcare

October 1, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 1, 2024 AMN HEALTHCARE SERVICES, INC.

August 9, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

August 8, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2024 AMN HEALTHCARE SERVICES, INC.

August 8, 2024 EX-99.1

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2024 RESULTS Quarterly revenue of $741 million; GAAP EPS of $0.42 and adjusted EPS of $0.98

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2024 RESULTS Quarterly revenue of $741 million; GAAP EPS of $0.42 and adjusted EPS of $0.98 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2024 financial results. Financial highlights are as follows: D

July 9, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 2, 2024 AMN HEALTHCARE SERVICES, INC.

May 10, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

May 10, 2024 EX-3.1

Second Amended and Restated Certificate of Incorporation of AMN Healthcare Services, Inc.*

Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION of AMN HEALTHCARE SERVICES, INC. AMN Healthcare Services, Inc., a corporation duly incorporated under the laws of the State of Delaware, hereby certifies as follows: FIRST: The present name of the corporation is AMN Healthcare Services, Inc. (the “Corporation”). The original Certificate of Incorporation of the Corporation was fil

May 9, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2024 AMN HEALTHCARE SERVICES, INC.

May 9, 2024 EX-99.1

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2024 RESULTS Quarterly revenue of $821 million; GAAP EPS of $0.45 and adjusted EPS of $0.97

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2024 RESULTS Quarterly revenue of $821 million; GAAP EPS of $0.45 and adjusted EPS of $0.97 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2024 financial results. Financial highlights are as follows: Dol

April 22, 2024 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 19, 2024 AMN HEALTHCARE SERVICES, INC.

March 5, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

March 5, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

March 5, 2024 DEF 14A

DEFINITIVE PROXY STATEMENT

February 23, 2024 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☑ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

February 22, 2024 EX-10.44

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - CEO (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.44 CEO Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan

February 22, 2024 EX-10.41

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - CEO (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.41 CEO Version AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), a

February 22, 2024 EX-97.1

AMN Healthcare Services,

Exhibit 97.1 AMN HEALTHCARE SERVICES, INC. Compensation Recoupment Policy In accordance with the applicable rules of The New York Stock Exchange (the “NYSE Rules”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) has adopted this Policy to provide for the recovery of awarded Incentive-Bas

February 22, 2024 EX-21.1

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2023 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Interim Solutions, LLC Delaware AMN Healthcare Language Services, Inc. Delaware AMN Healthcare Locum Tenens, Inc. Delaware AMN Hea

February 22, 2024 EX-10.45

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.45 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equi

February 22, 2024 EX-10.43

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.43 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and , (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity

February 22, 2024 EX-10.46

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (TSR) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.46 Executive Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Pla

February 22, 2024 EX-10.47

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - CEO (TSR) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.47 CEO Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as

February 22, 2024 EX-10.40

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Executive (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.40 Executive Version AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”

February 22, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

February 22, 2024 EX-10.42

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Non-Executive (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.42 Non-Executive Form AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Pl

February 22, 2024 EX-10.48

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (TSR) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.48 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity

February 21, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 17, 2024 AMN HEALTHCARE SERVICES, INC.

February 15, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 15, 2024 AMN HEALTHCARE SERVICES, INC.

February 15, 2024 EX-99.1

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS Quarterly revenue of $818 million; GAAP EPS of $0.33 and adjusted EPS of $1.32

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS Quarterly revenue of $818 million; GAAP EPS of $0.33 and adjusted EPS of $1.32 DALLAS – (February 15, 2024) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2023 financi

February 13, 2024 SC 13G

AMN / AMN Healthcare Services, Inc. / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment

SC 13G 1 amn21324.htm ROBECO INVESTMENT MANAGEMENT INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 AMN HEALTHCARE SERVICES INC (Name of Issuer) Common Stock (Title of Class of Securities) 001744101 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to

February 13, 2024 SC 13G/A

AMN / AMN Healthcare Services, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0279-amnhealthcareservices.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: AMN Healthcare Services Inc Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate b

November 6, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

November 2, 2023 EX-99.1

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2023 RESULTS Quarterly revenue of $853 million; GAAP EPS of $1.39 and adjusted EPS of $1.97

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2023 RESULTS Quarterly revenue of $853 million; GAAP EPS of $1.39 and adjusted EPS of $1.97 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2023 financial results. Financial highlights are as follows: Dol

November 2, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2023 AMN HEALTHCARE SERVICES, INC.

October 23, 2023 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 23, 2023 AMN HEALTHCARE SERVICES, INC.

October 23, 2023 EX-99.1

Monday, October 23, 2023

EXHIBIT 99.1 Date: Monday, October 23, 2023 Time: 8:00 a.m. ET Owner: Randy Reece Headline: AMN Healthcare to Acquire MSDR DALLAS, Oct. 23, 2023 (GLOBE NEWSWIRE) - AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced a definitive agreement to acquire MSDR for a purchase price of $300 million. MSDR cons

August 4, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

August 3, 2023 EX-99.1

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2023 RESULTS Quarterly revenue of $991 million; GAAP EPS of $1.55 and adjusted EPS of $2.38

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2023 RESULTS Quarterly revenue of $991 million; GAAP EPS of $1.55 and adjusted EPS of $2.38 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2023 financial results. Financial highlights are as follows: D

August 3, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 3, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 3, 2023 AMN HEALTHCARE SERVICES, INC.

July 20, 2023 S-8

As filed with the Securities and Exchange Commission on July 20, 2023

As filed with the Securities and Exchange Commission on July 20, 2023 Registration No.

July 20, 2023 EX-FILING FEES

Filing Fee Table

EXHIBIT 107 Calculation of Filing Fee Table Form S-8 (Form Type) AMN Healthcare Services, Inc.

July 20, 2023 EX-10.1

AMN Healthcare Services Employee Stock Purchase Plan.

EXHIBIT 10.1 AMN Healthcare Services, Inc. Employee Stock Purchase Plan Adopted by the Board of Directors: March 1, 2022 Approved by the Stockholders: May 6, 2022 1. General; Purpose. (a) The Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an opportunity to purchase shares of Common Stock. The Company, by means of the Plan, seeks to re

July 12, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 6, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 6, 2023 AMN HEALTHCARE SERVICES, INC.

May 19, 2023 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 17, 2023 AMN HEALTHCARE SERVICES, INC.

May 8, 2023 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2023 AMN HEALTHCARE SERVICES, INC.

May 5, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

May 5, 2023 EX-4.1

Third Amendment to Credit Agreement, dated as of February 10th, 2023, by and among AMN Healthcare, Inc., as borrower, the guarantors party thereto, the lenders identified on the signature pages thereto, as lenders, and Truist Bank, as administrative agent (Incorporated by reference to Exhibit 4.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, filed with the SEC on May 5, 2023).

Exhibit 4.1 EXECUTION VERSION THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of February 10, 2023, is entered into among AMN HEALTHCARE, INC., a Nevada corporation (the “Borrower”), AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Parent”), the Subsidiary Guarantors identified on the signature pages hereto, the lenders identifie

May 4, 2023 EX-99.1

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2023 RESULTS Quarterly revenue of $1.126 billion; GAAP EPS of $2.02 and adjusted EPS of $2.49

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2023 RESULTS Quarterly revenue of $1.126 billion; GAAP EPS of $2.02 and adjusted EPS of $2.49 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2023 financial results. Financial highlights are as follows: D

May 4, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2023 AMN HEALTHCARE SERVICES, INC.

April 4, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

April 4, 2023 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

April 4, 2023 DEF 14A

DEFINITIVE PROXY STATEMENT

Notice of Annual Meeting & Proxy Statement 2023AMN Healthcare is well positioned to continue to meet the needs of healthcare organizations in an era of workforce shortages.

February 22, 2023 EX-10.54

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (TSR) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.54 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 10.54 AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amen

February 22, 2023 EX-10.52

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Executive (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.52 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 10.52 AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to

February 22, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

February 22, 2023 EX-4.5

Description of Securities (Incorporated by reference to Exhibit 4.5 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 4.5 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2022, AMN Healthcare Services, Inc. has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: (1) our common stock; (2) our preferred stock. Our common stock trades on the New York Stock Exchange under

February 22, 2023 EX-21.1

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2022 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Language Services, Inc. Delaware AMN Leadership Solutions, Inc. Delaware AMN Services, LLC North Carolina AMN Staffing Services, L

February 22, 2023 EX-10.55

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Executive (Buy-Out) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.55 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 10.55 AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to

February 22, 2023 EX-10.53

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.53 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 10.53 AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan (as may be

February 16, 2023 8-K

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 10, 2023 AMN HEALTHCARE SERVICES, INC.

February 16, 2023 EX-99.1

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS Quarterly revenue of $1.13 billion, 4% above high end of guidance; GAAP EPS of $1.88 and adjusted EPS of $2.48

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS Quarterly revenue of $1.13 billion, 4% above high end of guidance; GAAP EPS of $1.88 and adjusted EPS of $2.48 DALLAS – (February 16, 2023) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth qu

February 9, 2023 SC 13G/A

AMN / AMN Healthcare Services, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: AMN Healthcare Services Inc. Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is

December 16, 2022 EX-3.1

Eleventh Amended and Restated By-laws of AMN Healthcare Services, Inc. dated December 14, 2022 (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K dated December 14, 2022, filed with the SEC on December 16, 2022).

EXHIBIT 3.1 ELEVENTH AMENDED AND RESTATED BY-LAWS of AMN HEALTHCARE SERVICES, INC. (A Delaware Corporation) ARTICLE 1 DEFINITIONS As used in these By-laws, unless the context otherwise requires, the term: 1.1 “Assistant Secretary” means an Assistant Secretary of the Corporation. 1.2 “Assistant Treasurer” means an Assistant Treasurer of the Corporation. 1.3 “Board” means the Board of Directors of t

December 16, 2022 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 14, 2022

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 14, 2022 AMN HEALTHCARE SERVICES, INC.

November 4, 2022 EX-10.1

Form of AMN Healthcare Equity Plan Restricted Stock Unit Agreement—Director (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, filed with the SEC on November 4, 2022).

Exhibit 10.1 AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this DATE by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and NAME (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare Equity Plan (the ?Plan?), and desires to afford the Grantee the opportunity

November 4, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

November 4, 2022 EX-10.2

Severance Agreement, effective as of November 28, 2022, between AMN Healthcare, Inc. and Cary Grace (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, filed with the SEC on November 4, 2022).

Exhibit 10.2 SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the ?Agreement?), entered into by and between AMN Healthcare, Inc. (the ?Company?) and Cary Grace (?Executive?), is effective as of November 28, 2022 (the ?Effective Date?). 1.Employment at Will. The Company agrees to employ Executive, and Executive hereby agrees to be employed by the Company upon such terms and conditions as are mutually

November 3, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2022 AMN HEALTHCARE SERVICES, INC.

November 3, 2022 EX-99.1

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2022 RESULTS Quarterly revenue of $1.139 billion; GAAP EPS of $2.10 and adjusted EPS of $2.57

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2022 RESULTS Quarterly revenue of $1.139 billion; GAAP EPS of $2.10 and adjusted EPS of $2.57 DALLAS ? AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2022 financial results. Financial highlights are as follows: D

October 31, 2022 EX-99.1

AMN HEALTHCARE SELECTS CARY GRACE AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

EXHIBIT 99.1 NEWS RELEASE AMN HEALTHCARE SELECTS CARY GRACE AS PRESIDENT AND CHIEF EXECUTIVE OFFICER Grace will succeed long-time leader Susan Salka in guiding company?s growth and culture DALLAS, October 31, 2022 ? AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced Cary Grace as the company?s next presiden

October 31, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 31, 2022 AMN HEALTHCARE SERVICES, INC.

August 5, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

August 5, 2022 EX-10.1

First Amendment to Employment Agreement, dated as of February 6, 2008, between AMN Healthcare Services, Inc. and Susan R. Nowakowski (aka Susan R. Salka) (Management Contract or Compensatory Plan or Arrangement).**

Exhibit 10.1 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT The Employment Agreement effective May 4, 2005 by and between AMN Healthcare Services, Inc., a Delaware corporation (the ?Company?), and Susan R. Nowakowski, an individual (the ?Executive?), is hereby amended as follows: 1.Subsection 6(a) is hereby amended by deleting the second sentence thereof and substituting therefor the following: ?In addit

August 4, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 4, 2022 AMN HEALTHCARE SERVICES, INC.

August 4, 2022 EX-99.1

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2022 RESULTS Quarterly revenue of $1.427 billion; GAAP EPS of $2.77 and adjusted EPS of $3.31

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2022 RESULTS Quarterly revenue of $1.427 billion; GAAP EPS of $2.77 and adjusted EPS of $3.31 DALLAS ? AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2022 financial results. Financial highlights are as follows:

June 15, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 10, 2022 AMN HEALTHCARE SERVICES, INC.

June 15, 2022 EX-99.1

AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program

EXHIBIT 99.1 AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program DALLAS, June 15, 2022 - The Board of Directors (the ?Board?) of AMN Healthcare Services, Inc. (NYSE: AMN, the ?Company?) authorized an additional $250 million under the Company?s repurchase program for the company?s common stock (the ?Increased Company Repurchase Program?). The Company has repurchased 6.76 m

May 11, 2022 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2022 AMN HEALTHCARE SERVICES, INC.

May 6, 2022 EX-10.3

Transition Agreement, dated as of May 5, 2022, between AMN Healthcare, Inc. and Susan R. Salka (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.3 May 5, 2022 Susan R. Salka c/o AMN Healthcare Services, Inc. Re: Transition Agreement Dear Susan: In March 2022, you informed AMN Healthcare Services, Inc. (?AMN?, and together with AMN Healthcare, Inc. and their subsidiaries, the ?Company?) that you intended to retire from your employment with the Company in 2022 following the Company?s appointment of your successor. This letter sets

May 6, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

May 6, 2022 EX-10.4

Amendment to Restricted Stock Unit Agreements, dated as of May 5, 2022, between AMN Healthcare Services, Inc. and Jeffrey Knudson (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.4 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 6, 2022).

Exhibit 10.4 AMENDMENT TO RESTRICTED STOCK UNIT AGREEMENTS THIS AMENDMENT to RESTRICTED STOCK UNIT AGREEMENTS (the ?Amendment?) is made and entered into as of May 5, 2022, (the "Amendment Date") by and between AMN Healthcare Services, Inc. a Delaware corporation, (the ?Company?) and Jeffrey Knudson (?Grantee?). W I T N E S S E T H: WHEREAS, on November 2, 2021, Company granted Grantee restricted s

May 6, 2022 EX-10.5

AMN Healthcare 2022 Senior Executive Performance and Retention Bonus Plan (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.5 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 6, 2022).

Exhibit 10.5 AMN HEALTHCARE SERVICES, INC. 2022 PERFORMANCE AND RETENTION PLAN I. Purpose The purpose of this Plan is to provide for incentive compensation for Participants that is directly related to the 2022 Adjusted EBITDA results of the Company. This Plan provides for a potential Bonus Award payment to Participants, contingent upon continued employment and the achievement of Adjusted EBITDA th

May 6, 2022 EX-10.1

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 6, 2022).

Exhibit 10.1 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this , by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Pl

May 6, 2022 EX-10.2

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 6, 2022).

Exhibit 10.2 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this , by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equit

May 5, 2022 EX-99.1

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2022 RESULTS Quarterly revenue of $1.553 billion; GAAP EPS of $3.09 and adjusted EPS of $3.49

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2022 RESULTS Quarterly revenue of $1.553 billion; GAAP EPS of $3.09 and adjusted EPS of $3.49 DALLAS ? AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2022 financial results. Financial highlights are as follows: D

May 5, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 5, 2022 AMN HEALTHCARE SERVICES, INC.

March 24, 2022 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

March 24, 2022 DEF 14A

DEFINITIVE PROXY STATEMENT

March 24, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14

March 10, 2022 EX-99.1

AMN Healthcare Announces CEO Susan Salka Intends to Retire by End of Year

EXHIBIT 99.1 AMN Healthcare Announces CEO Susan Salka Intends to Retire by End of Year DALLAS, March 10, 2022 ? AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced Susan Salka, its President and Chief Executive Officer, intends to retire by the end of the year upon the naming of her successor. "AMN Healthcar

March 10, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 7, 2022 AMN HEALTHCARE SERVICES, INC.

February 24, 2022 EX-10.5

First Amendment to Office Lease, dated as of May 31, 2002, between Kilroy Realty, L.P. and AMN Healthcare, Inc. (Incorporated by reference to Exhibit 10.5 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 24, 2022).

Exhibit 10.5 FIRST AMENDMENT TO OFFICE LEASE THIS FIRST AMENDMENT TO OFFICE LEASE ("First Amendment") is made as of May 31, 2002, by and between KILROY REALTY, L.P., a Delaware limited partnership ("Landlord") and AMN HEALTHCARE, INC., a Nevada corporation ("Tenant"). R E C I T A L S : A.Landlord and Tenant entered into that certain Office Lease, dated April 2, 2002 (the "Lease"), whereby Landlord

February 24, 2022 EX-10.6

Second Amendment to Office Lease, dated as of June 30, 2006, between Kilroy Realty, L.P. and AMN Healthcare, Inc. (Incorporated by reference to Exhibit 10.6 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 24, 2022).

Exhibit 10.6 SECOND AMENDMENT TO OFFICE LEASE THIS SECOND AMENDMENT TO OFFICE LEASE ("Second Amendment") is made as of June 30, 2006, by and between KILROY REALTY, L.P., a Delaware limited partnership ("Landlord") and AMN HEALTHCARE, INC., a Nevada corporation ("Tenant"). R E C I T A L S : A.Landlord and Tenant entered into that certain Office Lease, dated April 2, 2002 (the "Office Lease"), as am

February 24, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

February 24, 2022 EX-21.1

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2021 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Language Services, Inc. Delaware AMN Leadership Solutions, Inc. Delaware AMN Services, LLC North Carolina AMN Staffing Services, L

February 24, 2022 EX-10.9

Fourth Amendment to Office Lease, dated as of October 5, 2021, between Kilroy Realty, L.P. and AMN Healthcare, Inc. (Incorporated by reference to Exhibit 10.9 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 24, 2022).

Exhibit 10.9 FOURTH AMENDMENT TO OFFICE LEASE This FOURTH AMENDMENT TO OFFICE LEASE ("Fourth Amendment") is made and entered into as of the 5th day of October, 2021, by and between KILROY REALTY, L.P., a Delaware limited partnership ("Landlord"), and AMN HEALTHCARE, INC., a Nevada corporation ("Tenant"). R E C I T A L S : A.Landlord and Tenant entered into that certain Office Lease, dated April 2,

February 17, 2022 EX-99.1

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS Quarterly revenue of $1.36 billion, up 116% over prior year; GAAP EPS of $2.42 and adjusted EPS of $2.95

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS Quarterly revenue of $1.

February 17, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 17, 2022 AMN HEALTHCARE SERVICES, INC.

February 9, 2022 SC 13G/A

AMN / AMN Healthcare Services, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: AMN Healthcare Services Inc. Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is

January 10, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 10, 2022 AMN HEALTHCARE SERVICES, INC.

January 10, 2022 EX-99.1

AMN Healthcare Announces Preliminary Fourth Quarter 2021 Revenue; To Present at J.P. Morgan Healthcare Conference

AMN Healthcare Announces Preliminary Fourth Quarter 2021 Revenue; To Present at J.

December 14, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2021 AMN HEALTHCARE SERVICES, INC.

November 10, 2021 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 AMN HEALTHCARE SERVICES, INC.

November 5, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

November 5, 2021 EX-10.1

Lease Termination Agreement, dated as of September 9, 2021, between Kilroy Realty, L.P. and AMN Healthcare, Inc.*

EXHIBIT 10.1 LEASE TERMINATION AGREEMENT This Lease Termination Agreement (this "Agreement") is entered into as of the 9th day of September, 2021 (the ?Effective Date?), by and between KILROY REALTY, L.P., a Delaware limited partnership (?Landlord?), and AMN HEALTHCARE, INC., a Nevada corporation (?Tenant?). R E C I T A L S : A.Landlord and Tenant entered into that certain Office Lease, dated Apri

November 4, 2021 EX-99.1

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2021 RESULTS Quarterly revenue of $878 million; GAAP EPS of $1.54 and adjusted EPS of $1.73

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2021 RESULTS Quarterly revenue of $878 million; GAAP EPS of $1.

November 4, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 4, 2021 AMN HEALTHCARE SERVICES, INC.

October 14, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 14, 2021 AMN HEALTHCARE SERVICES, INC.

October 14, 2021 EX-99.1

AMN Healthcare Names Jeffrey R. Knudson as Chief Financial Officer

EXHIBIT 99.1 AMN Healthcare Names Jeffrey R. Knudson as Chief Financial Officer DALLAS, Oct. 14, 2021 ? AMN Healthcare (NYSE:AMN), the nation?s largest total talent solutions provider in healthcare, announced the appointment of Jeffrey R. Knudson as the company?s Chief Financial Officer. He will join the leadership team at AMN on November 2, 2021. Knudson resides in Dallas with his family and come

August 6, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

August 5, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2021 AMN HEALTHCARE SERVICES, INC.

August 5, 2021 EX-99.1

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2021 RESULTS Quarterly revenue of $857 million; GAAP EPS of $1.39 and adjusted EPS of $1.64

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2021 RESULTS Quarterly revenue of $857 million; GAAP EPS of $1.

June 21, 2021 EX-99.1

June 16, 2021

EXHIBIT 99.1 June 16, 2021 Susan Salka AMN Healthcare Services, Inc. 8840 Cypress Waters Blvd. Coppell, TX 75019 Dear Susan: It is with mixed emotions that I am submitting my letter of resignation as the Chief Financial Officer, Chief Accounting Officer and Treasurer of AMN Healthcare, effective August 9, 2021. I joined AMN over 17 years ago and my time with the organization has not only defined m

June 21, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 16, 2021 AMN HEALTHCARE SERVICES, INC.

May 18, 2021 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2021 AMN HEALTHCARE SERVICES, INC.

May 10, 2021 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

May 10, 2021 EX-10.2

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement).*

EXHIBIT 10.2 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this , by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equit

May 10, 2021 EX-10.1

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement).*

EXHIBIT 10.1 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this , by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Pl

May 6, 2021 EX-99.1

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2021 RESULTS Quarterly revenue of $886 million; GAAP EPS of $1.47 and adjusted EPS of $1.70

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2021 RESULTS Quarterly revenue of $886 million; GAAP EPS of $1.

May 6, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2021 AMN HEALTHCARE SERVICES, INC.

April 23, 2021 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 21, 2021 AMN HEALTHCARE SERVICES, INC.

April 23, 2021 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A (Amendment No.

March 29, 2021 DEFA14A

- FORM DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ? Filed by the Registrant ? Filed by a Party other than the Registrant Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to ? 240.

March 10, 2021 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14

March 10, 2021 DEF 14A

DEFINITIVE PROXY STATEMENT

AMN Overview OUR ASPIRATION We strive to be recognized as the most trusted, innovative, and influential force in helping healthcare organizations provide a quality patient care experience that is more human, more effective, and more achievable.

March 10, 2021 DEFA14A

- DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

DEFA14A 1 amn3830011-defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confi

February 26, 2021 10-K

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

February 26, 2021 EX-21.1

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2020 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Leadership Solutions, Inc. Delaware AMN Services, LLC North Carolina AMN Staffing Services, LLC Delaware AMN Workforce Solutions, LLC Delawar

February 26, 2021 EX-4.5

Description of Securities.*

Exhibit 4.5 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2020, AMN Healthcare Services, Inc. has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: (1) our common stock; (2) our preferred stock. Our common stock trades on the New York Stock Exchange under

February 18, 2021 EX-99.1

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 RESULTS Quarterly revenue of $631 million, up 8% over prior year; GAAP EPS of $0.19 and adjusted EPS of $1.00

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 RESULTS Quarterly revenue of $631 million, up 8% over prior year; GAAP EPS of $0.

February 18, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2021 AMN HEALTHCARE SERVICES, INC.

February 10, 2021 SC 13G/A

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: AMN Healthcare Services Inc. Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is

January 11, 2021 EX-99.1

AMN Healthcare Announces Preliminary Fourth Quarter 2020 Revenue; To Present at J.P. Morgan Healthcare Conference

AMN Healthcare Announces Preliminary Fourth Quarter 2020 Revenue; To Present at J.

January 11, 2021 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 11, 2021 AMN HEALTHCARE SERVICES, INC.

November 6, 2020 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

November 6, 2020 EX-4.1

Indenture, dated as of October 20, 2020, by and among AMN Healthcare, Inc., the guarantors party thereto, and U.S. Bank National Association (Incorporated by reference to Exhibit 4.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, filed with the SEC on November 6, 2020).

Exhibit 4.1 Execution Version AMN HEALTHCARE, INC. THE GUARANTORS PARTY HERETO FROM TIME TO TIME 4.000% SENIOR NOTES DUE 2029 INDENTURE Dated as of October 20, 2020 U.S. BANK NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 31 SECTION 1.03. Rules of Construction 32 SECTION 1.04. No Incorporation by Reference o

November 5, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 5, 2020 AMN HEALTHCARE SERVICES, INC.

November 5, 2020 EX-99.1

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2020 RESULTS Quarterly revenue of $552 million; GAAP EPS of $0.55 and adjusted EPS of $0.82

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2020 RESULTS Quarterly revenue of $552 million; GAAP EPS of $0.

October 20, 2020 8-K

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 20, 2020 AMN HEALTHCARE SERVICES, INC.

October 5, 2020 EX-99.1

AMN Healthcare Launches $325.0 Million Offering Of Senior Notes

EXHIBIT 99.1 AMN Healthcare Launches $325.0 Million Offering Of Senior Notes DALLAS - October 5, 2020 - AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $325.0 million aggregate principal amount of senior unsecured notes due 2029 (the “2029 Notes”), subject to market and other conditions. The 20

October 5, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 1, 2020 AMN HEALTHCARE SERVICES, INC.

October 5, 2020 EX-99.2

AMN Healthcare Announces Pricing of Senior Notes Offering

EXHIBIT 99.2 AMN Healthcare Announces Pricing of Senior Notes Offering DALLAS - October 5, 2020 - AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $350.0 million aggregate principal amount of senior unsecured notes due 2029, which represents an increase of $25.0 million from the ag

October 5, 2020 8-K

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 5, 2020 AMN HEALTHCARE SERVICES, INC.

August 13, 2020 8-K

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 13, 2020 AMN HEALTHCARE SERVICES, INC.

August 10, 2020 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2020 AMN HEALTHCARE SERVICES, INC.

August 10, 2020 EX-99.1

AMN Healthcare Launches $150 Million Offering Of Senior Notes

EXHIBIT 99.1 AMN Healthcare Launches $150 Million Offering Of Senior Notes DALLAS and SAN DIEGO – August 10, 2020 - AMN Healthcare Services, Inc. (NYSE: AMN) (the “Company” or “AMN Healthcare”), announced today that its wholly owned subsidiary, AMN Healthcare, Inc. (the “Issuer”), intends to make a private offering of an additional $150 million aggregate principal amount of its 4.625% Senior Notes

August 10, 2020 EX-99.1

Certain Supplemental Financial Information

EXHIBIT 99.1 Certain Supplemental Financial Information Introduction As part of our preliminary offering memorandum that is being disseminated in connection with the Notes Offering, we are providing Further Adjusted EBITDA for the twelve months ended June 30, 2020 to give effect to (i) net cost savings and synergies projected by the Company to be realized as a result of certain operational initiat

August 10, 2020 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2020 AMN HEALTHCARE SERVICES, INC.

August 10, 2020 EX-99.2

AMN Healthcare Announces Upsize and Pricing of Senior Notes Offering

EXHIBIT 99.2 AMN Healthcare Announces Upsize and Pricing of Senior Notes Offering DALLAS and SAN DIEGO - August 10, 2020 - AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc. (the “Issuer”), priced its private offering of an additional $200 million aggregate principal amount of 4.625% Senior Notes due 2027, which represents an increase

August 10, 2020 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

August 6, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2020 AMN HEALTHCARE SERVICES, INC.

August 6, 2020 EX-99.1

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2020 RESULTS Quarterly revenue of $608 million; GAAP EPS of $0.47 and adjusted EPS of $0.83

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2020 RESULTS Quarterly revenue of $608 million; GAAP EPS of $0.

May 11, 2020 EX-99.1

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2020 RESULTS Quarterly revenue of $602 million; GAAP EPS of $0.27 and adjusted EPS of $0.79

EX-99.1 2 amn-ex991x20200331xear.htm EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2020 RESULTS Quarterly revenue of $602 million; GAAP EPS of $0.27 and adjusted EPS of $0.79 DALLAS & SAN DIEGO – (May 11, 2020) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarte

May 11, 2020 EX-10.2

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 11, 2020).

EXHIBIT 10.2 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2020, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017

May 11, 2020 EX-10.4

Form of Amended and Restated Severance Agreement, effective as of May 8, 2020 (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 11, 2020).

EXHIBIT 10.4 AMENDED AND RESTATED SEVERANCE AGREEMENT THIS AMENDED AND RESTATED SEVERANCE AGREEMENT (the “Agreement”), entered into by and between AMN Healthcare, Inc. (the “Company”) and [EXECUTIVE] (“Executive”), was originally effective as of February 19, 2019, is amended and restated effective as of May 8, 2020 (the “Amendment Date”). 1.Employment at Will. The Company agrees to employ Executiv

May 11, 2020 EX-4.1

Second Amendment to Credit Agreement, dated as of February 14, 2020, by and among AMN Healthcare, Inc., as borrower, the guarantors party thereto, the lenders identified on the signature pages thereto, as lenders, and SunTrust Bank, as administrative agent (Incorporated by reference to Exhibit 4.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 11, 2020).

EXHIBIT 4.1 EXECUTION VERSION SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of February 14, 2020, is entered into among AMN HEALTHCARE, INC., a Nevada corporation (the “Borrower”), AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Parent”), the Subsidiary Guarantors identified on the signature pages hereto, the lenders identif

May 11, 2020 EX-10.3

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement (Stratus Gross Profit) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 11, 2020).

EXHIBIT 10.3 AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (Stratus Gross Profit) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2020, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be a

May 11, 2020 EX-10.1

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 11, 2020).

EXHIBIT 10.1 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2020, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equ

May 11, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 11, 2020 AMN HEALTHCARE SERVICES, INC.

May 11, 2020 EX-99.2

AMN Healthcare Segment Reporting Realignment (Unaudited) During the first quarter 2020 earnings release, AMN Healthcare Services, Inc. (NYSE: AMN) announced an update to our reportable segments. Effective January 1, 2020, our three reportable segment

historicalsegmentreporti AMN Healthcare Segment Reporting Realignment (Unaudited) During the first quarter 2020 earnings release, AMN Healthcare Services, Inc.

May 11, 2020 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

May 1, 2020 EX-99.1

Independent Auditor’s Report

EXHIBIT 99.1 Stratus Video Holding Company and Subsidiaries Consolidated Financial Statements December 31, 2019 Stratus Video Holding Company and Subsidiaries Index As of and for the Year Ended December 31, 2019 Page(s) Independent Auditor’s Report 1–2 Consolidated Financial Statements Balance Sheet 3 Statement of Income and Comprehensive Income 4 Statement of Changes in Stockholder’s Equity 5 Sta

May 1, 2020 8-K/A

Financial Statements and Exhibits - AMENDMENT NO. 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A (Amendment No.

May 1, 2020 EX-99.2

UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION

EXHIBIT 99.2 UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION On February 14, 2020, AMN Healthcare, Inc., a Nevada corporation (the “Company”), a wholly owned subsidiary of AMN Healthcare Services, Inc., a Delaware corporation (“AMN”), completed its acquisition (the “Acquisition”) of Stratus Video Holding Company, a Delaware corporation (“Stratus Video”), pursuant to the terms of a Stock Purchas

April 27, 2020 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 22, 2020 AMN HEALTHCARE SERVICES, INC.

April 27, 2020 EX-3.2

Tenth Amended and Restated Bylaws of AMN Healthcare Services, Inc. dated April 22, 2020 (Incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K dated April 22, 2020, filed with the SEC on April 27, 2020).

EXHIBIT 3.2 TENTH AMENDED AND RESTATED BY-LAWS of AMN HEALTHCARE SERVICES, INC. (A Delaware Corporation) ARTICLE 1 DEFINITIONS As used in these By-laws, unless the context otherwise requires, the term: 1.1 “Assistant Secretary” means an Assistant Secretary of the Corporation. 1.2 “Assistant Treasurer” means an Assistant Treasurer of the Corporation. 1.3 “Board” means the Board of Directors of the

April 3, 2020 EX-99.1

AMN Healthcare to Hold Virtual 2020 Annual Meeting of Shareholders

EXHIBIT 99.1 AMN Healthcare to Hold Virtual 2020 Annual Meeting of Shareholders DALLAS and SAN DIEGO, April 3, 2020 /PRNewswire/ - AMN Healthcare Services, Inc. (NYSE: AMN) today announced that, due to public health concerns relating to the novel coronavirus (COVID-19) pandemic, and to protect the health and well-being of its shareholders, directors and employees, AMN’s 2020 Annual Meeting of Shar

April 3, 2020 DEFA14A

AHS / AMN Healthcare Services, Inc. DEFA14A - - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defini

April 3, 2020 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 3, 2020 AMN HEALTHCARE SERVICES, INC.

March 11, 2020 DEFA14A

AHS / AMN Healthcare Services, Inc. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☑ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.

March 11, 2020 DEF 14A

AHS / AMN Healthcare Services, Inc. DEF 14A - - DEF 14A

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.

March 3, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2020 AMN HEALTHCARE SERVICES, INC.

February 26, 2020 PRE 14A

AHS / AMN Healthcare Services, Inc. PRE 14A - - PRE 14A

PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.

February 25, 2020 EX-21.1

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2019 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, Inc. Florida AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Leadership Solutions, Inc. Delaware AMN Services, LLC North Carolina AMN Staffing Services, LLC Delaware AMN Vision Services, LLC Delaware AM

February 25, 2020 EX-10.36

Executive Severance Agreement between AMN Healthcare, Inc. and Ralph Henderson, effective as of February 19, 2019 (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.36 SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the “Agreement”), dated February 19, 2019, between AMN Healthcare, Inc. (the “Company”) and Ralph S. Henderson (“Executive”). 1.Employment at Will. The Company agrees to employ Executive and Executive hereby agrees to be employed by the Company upon such terms and conditions as are mutually agreed upon. Executive’s employment with the Com

February 25, 2020 EX-10.37

Executive Severance Agreement between AMN Healthcare, Inc. and Brian M. Scott, effective as of February 19, 2019 (Management Contract or Compensatory Plan or Arrangement).*

EX-10.37 5 amn-ex1037x20191231x10k.htm EXHIBIT 10.37 Exhibit 10.37 SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the “Agreement”), dated effective as of February 19, 2019, is entered into by and between AMN Healthcare, Inc. (the “Company”) and Brian M. Scott (“Executive”). 1.Employment at Will. The Company agrees to employ Executive and Executive hereby agrees to be employed by the Company upon su

February 25, 2020 10-K

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

February 25, 2020 EX-10.35

Executive Severance Agreement between AMN Healthcare, Inc. and Denise L. Jackson, effective as of February 19, 2019 (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.35 SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the “Agreement”), dated effective as of February 19, 2019, is entered into by and between AMN Healthcare, Inc. (the “Company”) and Denise L. Jackson (“Executive”). 1.Employment at Will. The Company agrees to employ Executive and Executive hereby agrees to be employed by the Company upon such terms and conditions as are mutually agreed upo

February 25, 2020 EX-4.4

Description of Securities.*

Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2019, AMN Healthcare Services, Inc. has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: (1) our common stock; (2) our preferred stock. Our common stock trades on the New York Stock Exchange under

February 18, 2020 8-K

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 14, 2020 AMN HEALTHCARE SERVICES, INC.

February 18, 2020 EX-2.1

Stock Purchase Agreement, dated as of January 26, 2020, by and among AMN Healthcare, Inc., Stratus Video 2016 Group, LLC and Stratus Video Holding Company (Incorporated by reference to Exhibit 2.1 of the Registrant’s Current Report on Form 8-K dated February 14, 2020, filed with the SEC on February 18, 2020).

EXHIBIT 2.1 EXECUTION VERSION STOCK PURCHASE AGREEMENT by and among STRATUS VIDEO 2016 GROUP, LLC, STRATUS VIDEO HOLDING COMPANY, and AMN HEALTHCARE, INC., DATED AS OF JANUARY 26, 2020 TABLE OF CONTENTS Page ARTICLE 1 CERTAIN DEFINITIONS 1 Section 1.1 Certain Definitions 1 ARTICLE 2 CLOSING; PURCHASE 15 Section 2.1 Closing of the Transaction 15 Section 2.2 Share Purchase 15 Section 2.3 Purchase Pr

February 13, 2020 EX-99.1

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 RESULTS Quarterly revenue of $587 million, up 11% over prior year; GAAP EPS of $0.58 and adjusted EPS of $0.85

Contact: Randle Reece Director, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 RESULTS Quarterly revenue of $587 million, up 11% over prior year; GAAP EPS of $0.58 and adjusted EPS of $0.85 DALLAS and SAN DIEGO – (February 13, 2020) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in healthcare total talent solutions, today announced

February 13, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 13, 2020 AMN HEALTHCARE SERVICES, INC.

February 12, 2020 SC 13G/A

AHS / AMN Healthcare Services, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: AMN Healthcare Services Inc Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is

January 29, 2020 8-K

Entry into a Material Definitive Agreement, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 26, 2020 AMN HEALTHCARE SERVICES, INC.

January 23, 2020 EX-3.1

Ninth Amended and Restated Bylaws of AMN Healthcare Services, Inc. dated January 17, 2020 furnished pursuant to Item 5.03 of this Current Report on Form 8-K.

NINTH AMENDED AND RESTATED BY-LAWS of AMN HEALTHCARE SERVICES, INC. (A Delaware Corporation) ARTICLE 1 DEFINITIONS As used in these By-laws, unless the context otherwise requires, the term: 1.1 “Assistant Secretary” means an Assistant Secretary of the Corporation. 1.2 “Assistant Treasurer” means an Assistant Treasurer of the Corporation. 1.3 “Board” means the Board of Directors of the Corporation.

January 23, 2020 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 17, 2020 AMN HEALTHCARE SERVICES, INC.

January 10, 2020 CORRESP

AHS / AMN Healthcare Services, Inc. CORRESP - -

AMN Healthcare Services, Inc. 12400 High Bluff Drive Suite 100 San Diego, California 92130 January 10, 2020 VIA EDGAR Amy Geddes Office of Trade & Services Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: AMN Healthcare Services, Inc. Form 10-K for the Year Ended December 31, 2018 Filed February 21, 2019 Form 8-K filed October 31, 2019 File No. 001-167533 Dear Ms. G

December 23, 2019 CORRESP

AHS / AMN Healthcare Services, Inc. CORRESP - -

AMN Healthcare Services, Inc. 12400 High Bluff Drive Suite 100 San Diego, California 92130 December 23, 2019 VIA EDGAR Amy Geddes Office of Trade & Services Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: AMN Healthcare Services, Inc. Form 10-K for the Year Ended December 31, 2018 Filed February 21, 2019 Form 8-K filed October 31, 2019 File No. 001-167533 Dear Ms.

November 4, 2019 EX-4.1

Indenture, dated as of October 1, 2019, by and among AMN Healthcare, Inc., the guarantors party thereto, and U.S. Bank National Association (Incorporated by reference to Exhibit 4.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, filed with the SEC on November 4, 2019).

Exhibit 4.1 EXECUTION VERSION AMN HEALTHCARE, INC. THE GUARANTORS PARTY HERETO FROM TIME TO TIME 4.625% SENIOR NOTES DUE 2027 INDENTURE Dated as of October 1, 2019 U.S. BANK NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 30 SECTION 1.03. Rules of Construction 31 SECTION 1.04. No Incorporation by Reference of

November 4, 2019 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

October 31, 2019 EX-99.1

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2019 RESULTS Quarterly revenue of $568 million; GAAP EPS of $0.49 and adjusted EPS of $0.81

Contact: Randle Reece Director, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2019 RESULTS Quarterly revenue of $568 million; GAAP EPS of $0.49 and adjusted EPS of $0.81 DALLAS & SAN DIEGO – (October 31, 2019) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in healthcare workforce solutions and staffing services, today announced its third quarter 2019

October 31, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 31, 2019 AMN HEALTHCARE SERVICES, INC.

October 1, 2019 8-K

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 1, 2019 AMN HEALTHCARE SERVICES, INC.

September 26, 2019 EX-99.2

AMN Healthcare Announces Pricing of Senior Notes Offering

EX-99.2 Exhibit 99.2 AMN Healthcare Announces Pricing of Senior Notes Offering DALLAS and SAN DIEGO — Sept. 26, 2019 — AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $300 million aggregate principal amount of Senior Notes due 2027. The Senior Notes will bear an interest rate of 4.625%

September 26, 2019 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 26, 2019 AMN HEALTHCARE SERVICES, INC.

September 26, 2019 EX-99.1

AMN Healthcare Launches $300 Million Offering Of Senior Notes

EX-99.1 Exhibit 99.1 AMN Healthcare Launches $300 Million Offering Of Senior Notes DALLAS and SAN DIEGO — Sept. 26, 2019 — AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $300 million aggregate principal amount of Senior Notes due 2027, subject to market and other conditions. The Senior Notes w

September 26, 2019 EX-99.1

Certain Supplemental Financial Information

EX-99.1 EXHIBIT 99.1 Certain Supplemental Financial Information Introduction Our historical financial statements do not reflect amounts attributable to any acquired entity for dates prior to such entity’s acquisition. We completed our acquisitions of Silversheet Inc. on January 30, 2019 and Advanced Medical Personnel Services, Inc. on June 14, 2019 (the “acquired entities”). Accordingly, our histo

September 26, 2019 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 26, 2019 AMN HEALTHCARE SERVICES, INC.

September 16, 2019 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 16, 2019 AMN HEALTHCARE SERVICES, INC.

August 7, 2019 EX-4.1

, the lenders identified on the signature pages thereto, as lenders, and SunTrust Bank, as administrative agent (Incorporated by reference to Exhibit 4.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2019, filed with the SEC on August 7, 2019).

Exhibit 4.1 EXECUTION VERSION FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of June 14, 2019, is entered into among AMN HEALTHCARE, INC., a Nevada corporation (the “Borrower”), AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Parent”), the Subsidiary Guarantors identified on the signature pages hereto, the lenders identified on

August 7, 2019 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

August 6, 2019 EX-99.1

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2019 RESULTS Quarterly revenue of $535 million; GAAP EPS of $0.61 and adjusted EPS of $0.77

Contact: Randle Reece Director, Investor Relations 866.861.3229 AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2019 RESULTS Quarterly revenue of $535 million; GAAP EPS of $0.61 and adjusted EPS of $0.77 DALLAS & SAN DIEGO – (August 6, 2019) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in healthcare workforce solutions and staffing services, today announced its second quarter 2019

August 6, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2019 AMN HEALTHCARE SERVICES, INC.

June 17, 2019 EX-2.1

Stock Purchase Agreement, dated as of April 29, 2019, by and among AMN Healthcare, Inc., Advanced Medical Holdings, LLC, and Advanced Medical Personnel Services, Inc. (Incorporated by reference to Exhibit 2.1 of the Registrant’s Current Report on Form 8-K dated June 14, 2019, filed with the SEC on June 17, 2019).

EX-2.1 Exhibit 2.1 Execution Version STOCK PURCHASE AGREEMENT BY AND AMONG AMN HEALTHCARE, INC., ADVANCED MEDICAL HOLDINGS LLC, AND ADVANCED MEDICAL PERSONNEL SERVICES, INC. Dated as of April 29, 2019 TABLE OF CONTENTS ARTICLE I—SALE AND PURCHASE OF SHARES 1 1.1 Sale and Purchase of Shares 1 1.2 Purchase Price 1 1.3 Adjustment Amount 2 1.4 Earnout Payment 5 1.5 Closing 7 ARTICLE II—REPRESENTATIONS

June 17, 2019 8-K

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Completion of Acquisition or Disposition of Assets

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2019 AMN HEALTHCARE SERVICES, INC.

May 3, 2019 EX-10.1

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Margin) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, filed with the SEC on May 3, 2019).

Exhibit 10.1 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA MARGIN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2019, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity P

May 3, 2019 EX-10.4

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (TSR)(Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.4 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, filed with the SEC on May 3, 2019).

Exhibit 10.4 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2019 by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equ

May 3, 2019 EX-10.5

Form of AMN Healthcare 2017 Equity Plan Restricted Stock Unit Agreement - Non-Executive (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.5 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, filed with the SEC on May 3, 2019).

Exhibit 10.5 Non-Executive Form AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2019, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, th

May 3, 2019 EX-10.3

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Margin) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.3 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, filed with the SEC on May 3, 2019).

Exhibit 10.3 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA MARGIN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2019, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equi

May 3, 2019 EX-10.2

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (TSR) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, filed with the SEC on May 3, 2019).

Exhibit 10.2 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2019 by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity

May 3, 2019 10-Q

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

Other Listings
MX:AMN
DE:HCQ € 17.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista